Ref (type) | Population | Outcome, Interventions | Results and statistical analysis | Effect size | Favours |
Adverse effects | |||||
RCT 3-armed trial |
74 people |
Pruritus
1/24 (4%) with triethanolamine polypeptide-based proprietary preparation 2/26 (8%) with carbamide peroxide-based proprietary preparation 0/24 (0%) with saline |
Significance not assessed |
||
RCT 3-armed trial |
74 people |
Discomfort
0/24 (0%) with triethanolamine polypeptide-based proprietary preparation 0/26 (0%) with carbamide peroxide-based proprietary preparation 1/24 (4%) with saline |
Significance not assessed |
||
RCT 3-armed trial |
74 people |
Contact dermatitis
1/24 (4%) with triethanolamine polypeptide-based proprietary preparation 0/26 (0%) with carbamide peroxide-based proprietary preparation 0/24 (0%) with saline |
Significance not assessed |
||
RCT 3-armed trial |
89 people |
Adverse events
with potassium carbonate/ethyl acohol/glycerol 480/thymol proprietary preparation with saline |